Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1749-4486.2010.02157.x | DOI Listing |
Auris Nasus Larynx
October 2018
Center for Microbial Genetics and Genomics, Northern Arizona University, Flagstaff, United States.
Objective: The incidence of refractory chronic rhinosinusitis (CRS) associated with methicillin-resistant Staphylococcus aureus (MRSA) is rising and remains a therapeutic challenge. The goal of this study is to demonstrate the efficacy of a non-invasive topical therapy against MRSA in these patients.
Methods: Seventeen patients with refractory CRS caused by MRSA were treated with a topical therapy protocol.
Ear Nose Throat J
April 2015
Department of Otolaryngology-Head and Neck Surgery, Union Memorial Hospital, 201 East University Pkwy., Baltimore, MD 21218, USA.
The management of refractory chronic rhinosinusitis (CRS) after endoscopic sinus surgery is complex and challenging. We conducted a prospective clinical pilot study to evaluate the effectiveness of a rhinotopic protocol for the treatment of refractory CRS. Our study population was made up of 20 patients--8 men and 12 women, aged 31 to 76 years (mean: 50.
View Article and Find Full Text PDFClin Otolaryngol
August 2010
Otolaryngology-Head and Neck Surgery, Johns Hopkins Hospital, Baltimore, MD, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!